Safety and efficacy of Razumab – The new biosimilar in India: Our experience

Safety and efficacy of Razumab – The new biosimilar in India: Our experience

Aim: The aim of this study was to evaluate the safety and efficacy of biosimilar intravitreal ranibizumab (Razumab) for the treatment of chorioretinal vascular diseases such as diabetic macular edema (DME), neovascular age-related macular degeneration (nAMD), and macular edema secondary to retinal v...

Full description

Bibliographic Details
Main Authors:	V V Sameera, A G Apoorva, Shrinivas Joshi, A S Guruprasad
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2016-01-01
Series:	Kerala Journal of Ophthalmology
Subjects:	Age-related macular degeneration diabetic macular edema Razumab retinal vein occlusion
Online Access:	http://www.kjophthal.com/article.asp?issn=0976-6677;year=2016;volume=28;issue=3;spage=180;epage=185;aulast=Sameera

Similar Items

Clinical efficacy and safety of Razumab® (CESAR) study: Our experience with the world's first biosimilar Ranibizumab
by: Lalit Verma, et al.
Published: (2021-01-01)

Clinical effectiveness and safety of razumab (a biosimilar of ranibizumab)
by: Sriram Gopal, et al.
Published: (2020-01-01)

Safety and efficacy of Razumab™ (world’s first biosimilar ranibizumab) in wet age-related macular degeneration: a post-marketing, prospective ASSET study
by: Shashikant Sharma, et al.
Published: (2021-03-01)

A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion
by: Shashikant Sharma, et al.
Published: (2020-07-01)

Study on the change of retinal thickness and choroidal thickness and correlative factors for macular edema after Ranibizumab injection
by: Guan-Lu Liang, et al.
Published: (2018-05-01)

Ranibizumab Biosimilars in Treating Retinal Disorders: A Cost-Effective Revolution?
by: Chatzimichail E, et al.
Published: (2024-02-01)

Clinical efficacy of intravitreous injection of Conbercept in the treatment of macular edema secondary to retinal branch vein occlusion
by: Hong-Liang Jia, et al.
Published: (2020-07-01)

Efficacy of first Ranibizumab intravitreal injection on macular edema caused by retinal vein occlusion
by: Hong Cao, et al.
Published: (2015-09-01)

INTRAVITREAL IMPLANT OF DEXAMETHASONE IN THE TREATMENT OF RETINAL VEIN OCCLUSION: EFFICACY AND SAFETY
by: A. E. Yavorskiy, et al.
Published: (2015-10-01)

Intravitreal injection of Ranibizumab combined with retinal photocoagulation for CRVO with retinal neovascularization and macular edema
by: Yong Wang
Published: (2018-06-01)

Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion in a Real Life Practice: A Retrospective Case Series
by: Abdullah Ozkaya, et al.
Published: (2016-12-01)

Efficacy and safety of Ziv-aflibercept in patients with central retinal vein occlusion
by: Amin E Nawar, et al.
Published: (2021-01-01)

The Dilemma between the Randomized Control Trials and Real Life Practice in the Treatment of Retinal Diseases with Intravitreal anti-VEGF agents
by: Abdullah Özkaya, et al.
Published: (2017-05-01)

Low health literacy levels in patients with chronic retinal disease
by: Sofie Jandorf, et al.
Published: (2019-08-01)

Visual outcomes, safety profile and morphometric response of optical coherence tomography biomarkers to ranibizumab biosimilar treatment in neovascular age-related macular degeneration: Real-world evidence
by: Aditya S Kelkar, et al.
Published: (2021-01-01)

Efficacy of intravitreal injection of Ranibizumab combined with 577nm laser in the treatment of macular edema associated with retinal vein occlusion
by: Xue-Fei Wang, et al.
Published: (2017-12-01)

Effects of different does intravitreous triamcinolone acetonide for macular edema secondary to retinal vein occlusion
by: Jing Su, et al.
Published: (2018-08-01)

Intravitreal ranibizumab improves macular sensitivity in patients with central retinal vein occlusion and macula edema
by: Taro Otawa, et al.
Published: (2022-06-01)

Treatment outcomes for maculopathy secondary to retinal vein occlusion in Afghanistan
by: Mohammad Delsoz, et al.
Published: (2024-01-01)

Twelve-month Outcomes of Dexamethasone Implant Treatment in Macular Edema Secondary to Retinal Vein Occlusion in Real Life
by: Abdullah Özkaya, et al.
Published: (2017-05-01)

The Major Role of Anti-Vascular Endothelial Growth Factor for Management of Macular Edema Secondary to Retinal Vein Occlusion
by: Hossam Elden Mohamed Ahmed Khalil, et al.
Published: (2021-06-01)

Ranibizumab versus Aflibercept in Macular Edema Secondary to Retinal Vein Occlusion in Real Life: A Retrospective Case Control Study
by: Abdullah Özkaya, et al.
Published: (2017-05-01)

Macular edema owing to retinal vein occlusion treated by intravitreal triamcinolone acetonide
by: Wei Liu, et al.
Published: (2013-07-01)

Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series
by: Singer MA, et al.
Published: (2016-12-01)

Aflibercept for macular edema after branch retinal vein occlusion
by: Mahmoud Abouhussein
Published: (2018-01-01)

A clinical trial on Conbercept for macular edema secondary to central retinal vein occlusion
by: Min Wang, et al.
Published: (2017-10-01)

Aqueous levels of erythropoietin in acute retinal vein occlusion with macular edema
by: Hyun Jin Shin, et al.
Published: (2014-06-01)

Combination of Ranibizumab with macular laser for macular edema secondary to branch retinal vein occlusion: one-year results from a randomized controlled double-blind trial
by: Shuang Song, et al.
Published: (2020-06-01)

Intraocular Injection of StivantⓇ (A Biosimilar to Bevacizumab): A Case Series
by: Ahmad Mirshahi, et al.
Published: (2021-01-01)

Effect of oral tranexamic acid on macular edema associated with retinal vein occlusion or diabetes
by: Takeyama M, et al.
Published: (2017-12-01)

Profile of patients receiving intravitreal anti-vascular endothelial growth factor injections during COVID-19-related lockdown
by: Manavi D Sindal, et al.
Published: (2021-01-01)

Efficacy and prognostic factors of Ranibizumab in the treatment of macular edema secondary to retinal vein occlusion
by: Zhi-Jun Shen, et al.
Published: (2022-10-01)

Efficacy of Formulated Posterior Subtenon Triamcinolone in Macular Edema secondary to Non–Ischemic Retinal Vein Occlusions
by: Ehab Tharwat, et al.
Published: (2022-06-01)

Real-world data in retinal diseases treated with anti-vascular endothelial growth factor (anti-VEGF) therapy – a systematic approach to identify and characterize data sources
by: Vincent Daien, et al.
Published: (2019-10-01)

Hyperbaric Oxygen Therapy for Recalcitrant Macular Edema Following Branch Retinal Vein Occlusion
by: Avadhesh Oli, et al.
Published: (2022-01-01)

Changes in Neurodegeneration and Visual Prognosis in Branch Retinal Vein Occlusion after Resolution of Macular Edema
by: Chanjoon Park, et al.
Published: (2024-01-01)

Cytokines and Pathogenesis of Central Retinal Vein Occlusion
by: Hidetaka Noma, et al.
Published: (2020-10-01)

Combination pharmacotherapy for macular edema associated with retinal vein occlusion
by: Guo Li, et al.
Published: (2019-02-01)

Intravitreal Injection of Brolucizumab for Recalcitrant Macular Edema due to Central Retinal Vein Occlusion: A Small Case Series
by: Debdulal Chakraborty, et al.
Published: (2022-11-01)

Combined dexamethasone intravitreal implant (Ozurdex) and macular grid laser versus combined intravitreal bevacizumab and macular grid laser in branch retinal vein occlusion with macular edema
by: Abdelrahman G Salman
Published: (2015-01-01)